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When dendritic cells (DCs) patrolling 
the perimeter of the lung encounter the 
bacterial intruder Mycobacterium tuberculo-
sis, they trigger a series of location-spe-
cific events that culminate in an immune 
attack on the bug. DCs first secrete the 
cytokine interleukin (IL)-12p40, which 
helps the cells migrate from the lung to 
the draining lymph node, where they 
present M. tuberculosis antigens to T cells. 
Once there, DCs pro-
duce IL-12p70 and IL-
23, which direct T cell 
priming and differentia-
tion. Ultimately, inter-
feron  (IFN)-–producing 
T cells are lured into 
the lung tissue where 
they do direct battle 
with the invaders.
Cooper’s first con-
tact with pathogens and 
the immune response 
occurred as a graduate 
student in Jenefer 
Blackwell’s laboratory 
at the London School 
of Hygiene & Tropical 
Medicine, where she 
studied changes in the 
expression of surface 
molecules on Leishma-
nia parasites in the guts of sand flies (1). 
Later, as a postdoc in David Sacks’ lab-
oratory at the National Institutes of 
Health (NIH) in Maryland, Cooper in-
vestigated the T cell response to Leish-
mania antigens in patients recovering 
from leishmaniasis (2). Cooper next 
headed west to Colorado State Univer-
sity, where she first demonstrated the 
essential role of IL-12 and IFN- in the 
control of M. tuberculosis (1–4). And 
now at the Trudeau Institute, on the 
shores of Saranac Lake in upstate New 
York, Cooper, along with her hus-
band John Pearl and the rest of her 
laboratory, is parsing out how cytok-
ines secreted by DCs and T cells help 
orchestrate host immune responses 
against pathogens (5).
THE PATH TO PATHOGENS
Why did you want to become a biologist?
Do you know David Attenborough, the 
British broadcaster and naturalist? Well, 
he was kind of an inspiration for me. In 
fact, I wanted to go and count rock hy-
raxes in the savannah.
How did you make the jump to 
Leishmania parasites? That’s a far cry 
from counting small, furry mammals.
My undergraduate project was on neu-
ronal development in chicks, and while 
I was working on that I got really ex-
cited about cell biology and also the in-
tricate interactions between hosts and 
pathogens. While I was fi  nishing my un-
dergraduate degree and preparing for 
fi  nal exams, I told my tutor that I was 
going to do a technical course and he 
said, “Oh, don’t be silly,  Andrea. You need 
to do your PhD!”
I got really excited as a scientist dur-
ing graduate school at the London 
School of Hygiene & Tropical Medi-
cine. My laboratory was working on 
mice, there were people doing human 
work, and there were also sand fly peo-
ple—sand flies are the vectors of Leish-
mania. So although I wasn’t really 
supposed to be working on sand flies, 
I got friendly with a guy who was do-
ing sand fly stuff and we did some ex-
periments together. And that was one of 
the papers for my thesis.
After graduate school, you were a postdoc 
at the NIH in Maryland. Interesting that 
once you moved to the US you never 
went back to work in the UK.
That’s what my parents said too. I prom-
ised them I was only leaving [England] 
for two years, but I was drawn into the 
terrifi  c resources that are available here. 
In Europe and the UK, scientists are a 
bit more constrained by funding so 
they’re always very careful, whereas in 
the US we have a lot more resources.
Your next stop was Colorado State, and 
I see that you switched pathogens there.
Shall I tell you the real story about that?
Sure!
I had some hunting friends, and we 
went out West to do falconry in Wyo-
ming. I really enjoyed the whole west-
ern experience and 
thought maybe we’d 
like to move out there 
to see what it’s like. 
David Russell [now at 
Cornell University Col-
lege of Veterinary Medi-
cine] was a good friend 
of David Sacks, and I 
also knew him because 
he was a postdoc study-
ing Leishmania when I was a graduate 
student in the UK. David Russell said he 
knew some people in Colorado who 
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had a program in Mycobacterium tubercu-
losis, which would be a good model for 
me to know. And so he introduced me 
to Ian Orme at Colorado State. And 
when Ian and I met up, we decided it 
would be a great match. It was very for-
tuitous. Ian energized me to a great de-
gree, not only about the science, but also 
about my career.
Do you still go hunting with falcons?
I still like to watch the birds, but it’s not
something that one can do as a hobby. 
The people who do falconry do it full-
time. But I’ve stood next to golden ea-
gles; I’ve stood next to gyrfalcons and all 
sorts of beautiful birds. You take them 
out hunting and it’s a combination of 
bird, dog, and human. There’s nothing 
artifi  cial involved, no guns or anything. 
You simply go out and if you’re lucky, 
you might get a sage grouse for dinner at 
the end of it.
COUNTERING DISEASE
How are the interleukins you’re 
investigating involved in the immune 
response to M. tuberculosis?
Tuberculosis highlights why we have such 
a complex immune system. Since infec-
tious disease is what the immune response 
is designed to counter, I think you need to 
probe the role of cytokines using infec-
tious diseases or diseases developed in a 
vertebrate host. The IL12p40 homodimer, 
for instance, seems to be involved in tak-
ing immature DCs from a nonresponsive 
to a responsive state in mice, 
allowing them to migrate in 
response to homeostatic 
chemokines.We’ve seen this 
in both tuberculosis-exposed 
DCs and DCs exposed to 
Yersinia pestis, which causes 
plague. The IL-12p70 het-
erodimer is required to maxi-
mize the IFN- response. In 
the absence of IL-12p70, al-
though we get initial control 
of bacterial growth, it’s not 
very long-lived. So IL-12p70 
seems to be required to 
maintain long-lived, maximal 
IFN- responses within the 
tissue. In the absence of IL-23, which 
drives the expansion of IL-17-producing 
T cells, we don’t see a clear impact on in-
fection for the fi  rst 100 days, but it seems 
that there may be an impact later, and 
we’re working on that right now. We do 
know that in the absence of IL-23, you 
lose a substantial portion of the IL-17 re-
sponse to M. tuberculosis.
What has your laboratory learned 
about the immune response induced by 
tuberculosis vaccines?
Vaccine-induced memory is slow to re-
spond to aerosol delivery of M. tuberculo-
sis. We think this is why vaccination 
works well to limit disseminated disease, 
but is less eff   ective against pulmonary 
disease. We examined the early cellular 
response to aerosol infection of vacci-
nated mice and found that an early vac-
cine-dependent IL-17 response occurs 
in the lung, and this coincides with an 
accelerated local chemokine response. If 
this early IL-17 response is missing, then 
vaccine-induced memory in the form of 
an accelerated IFN- response doesn’t 
occur. By investigating the nature of the 
earliest cellular response in the lungs of 
vaccinated animals, we may be able to 
accelerate the memory response and im-
prove vaccination protocols.
SHORES OF THE SARANAC
You’re based in Saranac Lake, which 
looks pretty isolated. What’s it like 
raising a family there?
I’m very fortunate to have a very support-
ive husband who’s here at the institute 
with me. Together we’ve made the labora-
tory work very nicely. And we have a 
four-year-old son who just loves to do ex-
periments. He’s always drawing graphs 
and things like that. We 
have a daycare at the in-
stitute that’s been a ter-
rifi  c  environment.  And 
we have a beach! You’ve 
done your grant submis-
sion, you’ve sweated 
through the night trying 
to get it done and sub-
mitted, and then you go 
down to the beach for ei-
ther a swim or an ice 
skate, depending on the 
season. It’s very, very nice.
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Cooper and family on Trudeau Institute's beach.
T cells (red) and B cells (green) in a Mycobacterium 
tuberculosis-infected mouse lung.
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"Since infec-
tious disease 
is what the 
immune 
response is 
designed to 
counter, 
I think you 
need to probe 
the role of 
cytokines using 
infectious 
diseases.”